Human Apolipoprotein E (Apo E) ELISA Kit

$407.00

Catalog Number: EA8003-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Sandwich ELISA

Entrez Gene

348

Components

Biotinylated Human Apolipoprotein E Antibody, Chromogen Substrate (1x), EIA Diluent Concentrate (10x), Human Apolipoprotein E Microplate, Human Apolipoprotein E Standard, Sealing Tapes, SP Conjugate (100x), Standard Diluent (1x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

3.5 ng/ml

Range

0.008 – 0.5 ug/ml

Samples Type

CSF, Plasma, Serum

Associated Disease

Alzheimer's Disease, Cancer, Cardiovascular, Heart Disease

Species

Human

UniProt

P02649

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (27 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11–13 weeks?

  • https://karger.com/fdt/article-abstract/30/1/53/135789
  • AL Mastricci, R Akolekar, R Kuppusamy… - Fetal diagnosis and …, 2011 - karger.com
  • Objective: The aim of this study is to identify potential biomarkers for fetal trisomy 21 from previous publications using proteomic techniques and examine the potential value of such …

* Nowak JK et al. (2021) Preclinical atherosclerosis in cystic fibrosis: Two distinct presentations are related to pancreatic status. J Cyst Fibros. S1569-1993(21)01294-7.

* Jamka M et al. (2021) Comparison of the Effect of Amaranth Oil vs. Rapeseed Oil on Selected Atherosclerosis Markers in Overweight and Obese Subjects: A Randomized Double-Blind Cross-Over Trial. Int J Environ Res Public Health. 18(16):8540.

* Shieh YT et al. (2020) Cyclodextrin?micellar electrokinetic chromatography of apolipoproteins on human very low?density lipoprotein. Electrophoresis. 41(15):1333-1343.

* Nowak JK et al. (2019) Cystic fibrosis dyslipidaemia: A cross-sectional study. J Cyst Fibros. 18(4):566-571

* Jamka M et al. (2019) Comparison of the effects of endurance and endurance?strength training programmes on the level of endothelial dysfunction in women with abdominal obesity: study protocol for a randomised controlled trial. J. Med. Sci. 88(4):267-272.

* Hirose S et al. (2019) Apolipoprotein E binds to and reduces serum levels of DNA-mimicking, pyrrolated proteins. J Biol Chem. 294(28):11035-11045.

* Shcheglova EV et al. (2017) Genotypes and serum levels of apolipoprotein E and paraoxonase 1 in calcific aortic valve stenosis. Russian Cardiology J. 10 (150):107-112

* Raza SK et al. (2017) Serum amyloid A1 and plasminogen as predictory proteins to monitor the progression of preleukemic diseases towards acute lymphoblastic leukaemia. RSC Adv., 2017, 7, 29218-29226.

* Raza SK et al. (2017) 5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study. Sci Rep. 7(1):16440.

* Ray S et al. (2017) Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection. Sci Rep. 7(1):4400.

* Ray S et al. (2017) Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Sci Rep. 6:24557.

* Qureshi IZ et al. (2017) Serum APOE, leptin, CFH and HTRA1 levels in Pakistani age related macular degeneration patients. J Pak Med Assoc. 67(6):852-857.

* Aragones G et al. (2016) Proteomic profile of unstable atheroma plaque: increased neutrophil defensin 1, clusterin, and apolipoprotein E levels in carotid secretome. J Proteome Res. 15(3):933-44.

* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113

* Shcheglova EV et al. (2014) Gene ploymorphism of lipid metabolism markers in calcific aortic valve disease. Medical News of the North Caucasus. ISSN-2073-8137

* Sharma S et al. (2014) Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers. Sci Rep. 4:7140. doi: 10.1038/srep07140

* Saing T et al. (2014) Apolipoprotein E downregulates the production of IL-1 in individuals with HIV infection. J. South. California Clinicians. 8(1):34-36.

* Elena S et al. (2014) Gene polymorphism of lipid metabolism markers in calcific aortic valve disease.DOI - http://dx.doi.org/10.14300/mnnc.2014.09053. ISSN - 2073-8137

* Boeva OI et al. (2014) ANALYSIS OF INDICATORS OF LIPID METABOLIS IN CALCINATING DISEASES OF THE AORTAL VALVE. Basic research. 7(1):21-25

* Miyamoto-Sasaki M et al. (2013) Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb. 20(9):708-16.

* Felix K et al. (2013) Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. PLoS One. 8(12):e82755.

* Burgos-Ramos E et al. (2012) Central leptin and insulin administration modulates serum cytokine-and lipoprotein-related markers. Metabolism. 61(11):1646-57.

* Mastricci AL et al. (2011) Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks? Fetal Diagn Ther. 30(1):53-59

* Andres MA et al. (2011) APOE e4 allele and CSF APOE on Cognition in HIV-Infected Subjects. J Neuroimmune Pharmacol. 6(3): 389?398.

* Bencharif K et al. (2010) Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes. Lipids in Health and Disease 9:75

Loading data...